alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED FEBRUARY 22, 2024

NO. 03

- 24

- 00052

- CR

Rafael Antonio Rosado , Appellant

v.

The State of Texas , Appellee

APPEAL FROM THE 368TH DISTRICT COURT OF WILLIAMSON COUNTY

BEFORE JUSTICES BAKE R, TRIANA AND KELLY

DISMISSED ON APPELLANT’S MOTION

-- OPINION BY JUSTICE TRIANA

This is an appeal from the judgment of conviction entered by the tr i a l court

. Rafael Antonio

Rosado has file d a mot ion to dismiss the appeal. Therefore, the Court grants the motion, allows

Rafael Antonio Rosado to withdraw his notice of appeal, and dismisses the appeal. Because

appellant is indigent and u nable to pay costs, no adjudica t i on of costs is made.
No. 11-1279.

#### Johnson *v.*Bartos, Warden, et al.

C. A. 9th Cir. Certiorari denied.
<PAGE>   1


EXHIBIT 11--STATEMENT RE:  COMPUTATION OF PER SHARE EARNINGS


<TABLE>
<CAPTION>
                                      Three Months Ended             Six Months Ended
                                         September 30,                 September 30,
                                    ------------------------      -------------------------
                                      1995          1994             1995          1994
                                    -----------  -----------     -----------    -----------
<S>                                 <C>          <C>             <C>            <C>
PRIMARY:
   Average shares outstanding        10,719,608   10,087,535      10,715,716      8,739,983
   Net effect of dilutive stock
     options and warrants--based
     on the treasury stock method
     using average market price         430,835       99,841         417,701      1,335,747
                                    -----------  -----------     -----------    -----------
TOTAL                                11,150,443   10,187,376      11,133,417     10,075,730
                                    ===========  ===========     ===========    ===========

Net income                          $   302,000  $   220,000     $   809,000    $   717,000
                                    ===========  ===========     ===========    ===========

Per share amount                    $       .03  $       .02     $       .07    $       .07
                                    ===========  ===========     ===========    ===========

FULLY DILUTED:
   Average shares outstanding        10,719,608   10,087,535      10,715,716      8,739,983
   Net effect of dilutive stock
     options and warrants--based
     on the treasury stock method
     using the higher of ending
     or average market price            469,422      192,560         472,881      1,540,112
                                    -----------  -----------     -----------    -----------
TOTAL                                11,189,030   10,280,095      11,188,597     10,280,095
                                    ===========  ===========     ===========    ===========

Net income                          $   302,000  $   220,000     $   809,000    $   717,000
                                    ===========  ===========     ===========    ===========

Per share amount                    $       .03  $       .02     $       .07    $       .07
                                    ===========  ===========     ===========    ===========
</TABLE>


                                     -18-
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              APR-30-1999
<PERIOD-START>                                 MAY-01-1998
<PERIOD-END>                                   OCT-31-1998
<CASH>                                             303,441
<SECURITIES>                                             0
<RECEIVABLES>                                    3,183,282
<ALLOWANCES>                                       140,143
<INVENTORY>                                        163,533
<CURRENT-ASSETS>                                 4,194,881
<PP&E>                                           4,921,230
<DEPRECIATION>                                   2,376,126
<TOTAL-ASSETS>                                   7,144,782
<CURRENT-LIABILITIES>                            6,250,071
<BONDS>                                          1,388,244
<PREFERRED-MANDATORY>                            1,300,000
<PREFERRED>                                              0
<COMMON>                                             1,326
<OTHER-SE>                                      (1,794,859)
<TOTAL-LIABILITY-AND-EQUITY>                     7,144,782
<SALES>                                          7,960,310
<TOTAL-REVENUES>                                 7,960,310
<CGS>                                            5,527,535
<TOTAL-COSTS>                                    5,527,535
<OTHER-EXPENSES>                                         0
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                 434,051
<INCOME-PRETAX>                                    323,206
<INCOME-TAX>                                      (275,000)
<INCOME-CONTINUING>                                598,206
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                       598,206
<EPS-PRIMARY>                                          .04
<EPS-DILUTED>                                          .04
        


</TABLE>
# C_2021062EN.01004601.xml

| 22.2.2021 | EN | Official Journal of the European Union | C 62/46 |
| --- | --- | --- | --- |

22.2.2021

EN

Official Journal of the European Union

C 62/46

---

Action brought on 5 January 2021 — Advanced Superabrasives v EUIPO — Adi (ASI ADVANCED SUPERABRASIVES)

(Case T-4/21)

(2021/C 62/58)

Language in which the application was lodged: Polish

Parties

Applicant: Advanced Superabrasives, Inc. (Mars Hill, North Carolina, United States) (represented by: D. Piróg and A. Rytel, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Adi Srl (Thiene, Italy)

Details of the proceedings before EUIPO

Applicant for the trade mark at issue: Applicant

Trade mark at issue: Application for the EU figurative mark ‘ASI ADVANCED SUPERABRASIVES’ — Application No 17 163 734

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 23 October 2020 in Case R 2713/2019-2

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | order EUIPO to pay the costs |
| --- | --- |

—

order EUIPO to pay the costs

| — | in the event that the intervener intervenes in the proceedings, order that party to bear its own costs. |
| --- | --- |

—

in the event that the intervener intervenes in the proceedings, order that party to bear its own costs.

Pleas in law

| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |
| --- | --- |

—

Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;

| — | Infringement of Article 27(3)(b) of Commission Delegated Regulation (EU) 2018/625; |
| --- | --- |

—

Infringement of Article 27(3)(b) of Commission Delegated Regulation (EU) 2018/625;

| — | Infringement of Article 95(2) of Regulation (EU) 2017/1001 of the European Parliament and of the Council, in conjunction with Article 27(4) of Commission Delegated Regulation (EU) 2018/625; and |
| --- | --- |

—

Infringement of Article 95(2) of Regulation (EU) 2017/1001 of the European Parliament and of the Council, in conjunction with Article 27(4) of Commission Delegated Regulation (EU) 2018/625; and

| — | Infringement of Article 71(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council, in conjunction with Article 27(3)(b) of Commission Delegated Regulation (EU) 2018/625. |
| --- | --- |

—

Infringement of Article 71(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council, in conjunction with Article 27(3)(b) of Commission Delegated Regulation (EU) 2018/625.

---
Exhibit 31.1



CERTIFICATIONS



I, Paul C. Honda, certify that:



1. I have reviewed this report on Form 10-K and all reports
on Form 10-D required to be filed in respect of the period covered by this report on Form 10-K of Honda Auto Receivables 2015-1
Owner Trust (the “Exchange Act periodic reports”);



2. Based on my knowledge, the Exchange Act periodic reports,
taken as a whole, do not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;



3. Based on my knowledge, all of the distribution, servicing
and other information required to be provided under Form 10-D for the period covered by this report is included in the Exchange
Act periodic reports;



4. I am responsible for reviewing the activities performed by
the servicer and based on my knowledge and the compliance review conducted in preparing the servicer compliance statement required
in this report under Item 1123 of Regulation AB, and except as disclosed in the Exchange Act periodic reports, the servicer has
fulfilled its obligations under the servicing agreement in all material respects; and



5. All of the reports on assessment of compliance with servicing
criteria for asset-backed securities and their related attestation reports on assessment of compliance with servicing criteria
for asset-backed securities required to be included in this report in accordance with Item 1122 of Regulation AB and Exchange Act
Rules 13a-18 and 15d-18 have been included as an exhibit to this report, except as otherwise disclosed in this report. Any material
instances of noncompliance described in such reports have been disclosed in this report on Form 10-K.



In giving the certifications above, I have
reasonably relied on information provided to me by the unaffiliated party U.S. Bank National Association.



Date: June 10, 2015



|/s/ Paul C. Honda                                    | 
|---------------------------------------------------- | 
|Paul C. Honda                                        | 
|Vice President and Assistant Secretary               | 
|of American Honda Finance Corporation                | 
|(senior officer in charge of the servicing function) |
**EXHIBIT
      32.1**




**Certification
      Pursuant to**


**18
      U.S.C. Section 1350,**


**as
      Adopted Pursuant to**


**Section
      906 of the Sarbanes-Oxley Act of 2002**




In
      connection with the Quarterly Report of Telestone Technologies Corporation
      (the
      "Company") on Form 10-QSB for the period ended March 31, 2006 as filed with
      the
      Securities Exchange Commission on the date hereof (the Report), I, Han Daqing,
      Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. 1350,
      as
      adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
      that:




(1)
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company.




By:
            /s/ Han
              DaqingHan
              DaqingChief Executive OfficerMay 15, 2006
No. 11-1332.

#### Lord Abbett Municipal Income Fund, Inc. *v.*Strange, Attorney General of Alabama, et al.

C. A. 11th Cir. Certiorari denied.
**Exhibit
31.****2**
 
 **CERTIFICATION
OF CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY
ACT**
  I,
William J. Bush, certify that:
 
 1. I have
reviewed this quarterly report on Form 10-QSB of International Microcomputer
Software, Inc;
 
 2. Based on my
knowledge, this quarterly report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading;
 
 3. Based on my
knowledge, the financial statements, and other financial information included in
this quarterly report, fairly present in all material respects the financial
condition and results of operations of the registrant as of, and for, the
periods presented in this quarterly report;
 
 4. The
registrant's other certifying officer and I are responsible for establishing and
maintaining internal controls for the registrant and we have:
 
 a. Designed such
internal controls to ensure that material information relating to the registrant
and its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the periods in which this quarterly report is
being prepared;
 
 b. Evaluated the
effectiveness of the registrant's internal controls of a date within 90 days
prior to the filing date of this quarterly report (the "Evaluation Date");
and
 
 c. Presented in
this quarterly report our conclusions about the effectiveness of the internal
controls based on our evaluation as of the Evaluation Date.
 
 5. The
registrant's other certifying officer and I have disclosed, based on our most
recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):
 
 a. All
significant deficiencies in the design or operation of internal controls which
could adversely affect the registrant's ability to record, process, summarize
and report financial data and have identified for the registrant's auditors any
material weaknesses in internal controls; and
 
 b. Any fraud,
whether or not material, that involves management or other employees who have a
significant role in the registrant's internal controls.
 
 6. The
registrant's other certifying officer and I have indicated in this quarterly
report whether or not there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.
 
 ****
 **Date:
May 16, 2005**
 
 **By:  
/s/ William J. Bush**
 William
J. Bush
 Chief
Financial Officer (Principal Accounting Officer)
  -35-
No. 11-1394.

#### Ballan *v.*United States.

C. A. Armed Forces. Certiorari denied.
Order entered November 5, 2012 

## 004734

- In The


### No. 05-11-01663-CV MARQUIS ACQUISITION, INC., Appellant

V. STEADFAST INSURANCE COMPANY AND JULIE FRY, Appellees

On Appeal from the County Criminal Court No. 2

Dallas County, Texas Trial Court Cause No. CC-09-04702-B



### ORDER The Court has before it appellant’s August 28, 2012 motion for extension to file its reply 

### brief and appellees’ August 29, 2012 response to that motion, in which appellees state that they are unopposed. The Court GRANTS the motion and ORDERS the brief tendered by appellant on August 28, 2012 timely filed as of today’s date.

JUSTICE
Form Approved REPORT DOCUMENTATION PAGE OMS No. 0704·0788 

Public reponing burden tor tl'liS collection of ,nformatlon 1$ Istm.ted to average' hour per response. Including tn. 11m. for r8YIewtng Instructions. searching eXlltlng dati sources. 

gathering and maintaining the dati needed. and completing and revtewlng the collection of Information. Send COlM'tents regarding this burden est"".t. or any other aspect of thIS 

collection of Iniormatlon. Including suggestions for reducing thiS burden, to Washtngton HeadQuarters Set'VIC8S. Dffector.t. for Information Operations and Repons, 1215 JeHerson 

DaVIS HIghway. Sulle '204. Arlongton. VA 22202·4302. and to tn. Office of Mlnagement and Budget. Poperworl< ReductIon PrOlec:t 10704'()1B8). Wastllngton. DC 20503. 

1. AGENCY USE ONLY (Leave blank) 12. REPORT DATE 13. REPORT TYPE AND DATES COVERED 

May 1999 Technical 851009-920918 

4. TITLE AND SUBTITLE Operations Charioteer, Musketeer, 5. FUNDING NUMBERS

Touchstone, Cornerstone, Aqueduct, Sculpin, and Julin Tests C-DSWA IACRO-97-3020 

MILL YARD, DIAMOND BEECH,MIGHTY OAK,MIDDLE NOTE, MISSION 

IB¥~¥INTM~~~IO~ C~~i~oJfI~t;iT~~O, ~s~gNHWs ~1~HW- QUARRY, 

6. AUTHOR(S) 

Carole R. Schoengold 

7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION 

Bechtel Nevada REPOR:r NUMBER 

P.O. Box 98521 

Las Vegas, NV 89193-8521 

9. SPONSORING/MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSORING/MONITORING 

Defense Special Weapons Agency AGENCY REPORT NUMBER 

6801 Telegraph Road DSWA-6328F Alexandria, VA 22310-3398 

ESN/Schaeffer 

11 SUPPLEMENTARY NOTES 

N/A 

12a DISTRIBUTION/AVAILABILITY STATEMENT 12b. DISTRIBUTION CODE 

Approved for public release; distribution is unlimited. 

13 ABSTR':"CT {MaXImum 200 words) 

This report is a personnel-oriented history of DoD participation in underground 

nuclear weapons testing up to and during Operations Charioteer, Musketeer, 

Touchstone, Cornerstone, Aqueduct, Sculpin, and Julin; Tests MILL YARD, DIAMOND 

BEECH, MIGHTY OAK, MIDDLE NOTE, MISSION GHOST, MISSION CYBER, MISTY ECHO, DISKO ELM, 

MINERAL QUARRY, DISTANT ZENITH, DIAMOND FORTUNE, and HUNTERS TROPHY, 9 October 1985 

to 18 September 1992. It is the ninth in a series of historical reports which 

includes all DoD underground nuclear test participation from 1962 forward. In 

addition to these historical reports, a restricted distribution report (consisting 

of several volumes) identifies all DoD and DoD-affiliated participants, military, 

civilian, and DoD contractors, in both DoD and DOE tests, and lists their individual 

dose data. 

14 SUBJECT TERMS 15. NUMBER OF PAGES 

Defense Special Weapons Agency (DSWA) 

Centers for Disease Control (CDC) 16. PRICE CODE 

Underground Nuclear Test Personnel Review (UNTPR) 

17 SECURITY CLASSIFICATION 18 SECURITY CLASSIFICATION .19 SECURITY CLASSIFICATION 20 LIMITATION OF 

OF REPORT OF THIS PAGE OF ABSTRACT ABSTRACT 

UNCLASSIFIED UNCLASSIFIED UNCLASSIFIED SAR 

NSN 754,) 01 28C 550C Standard Form 298 (Rev ·2·89) 

PrescrIbed by ANSI Sla 239·' 8 

i 298· 102
Fourth Court of Appeals

San Antonio, Texas

JUDGMENT

No. 04-21-00063-CR

Derrick Wayne GRISSETT,

Appellant

v.

The STATE of Texas,

Appellee

From the 175th Judicial District Court, Bexar County, Texas

Trial Court No. 2021-CR-0493W

Honorable Catherine Torres-Stahl, Judge Presiding

BEFORE CHIEF JUSTICE MARTINEZ, JUSTICE RODRIGUEZ, AND JUSTICE 

VALENZUELA

In accordance with this court’s opinion of this date, this appeal is DISMISSED.

SIGNED September 29, 2021.

_________________________________

Liza A. Rodriguez, Justice
[Federal Register Volume 87, Number 68 (Friday, April 8, 2022)]
[Notices]
[Pages 20878-20879]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-07468]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Indian Health Service

RIN 0917-AA21


Reimbursement Rates for Calendar Year 2022

AGENCY: Indian Health Service, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is provided that the Acting Director of the Indian 
Health Service (IHS) has approved the rates for inpatient and 
outpatient medical care provided by the IHS facilities for Calendar 
Year 2022.

SUPPLEMENTARY INFORMATION: The Acting Director of the Indian Health 
Service (IHS), under the authority of sections 321(a) and 322(b) of the 
Public Health Service Act (42 U.S.C. 248 and 249(b)), Public Law 83-568 
(42 U.S.C. 2001(a)), and the Indian Health Care Improvement Act (25 
U.S.C. 1601 et seq.), has approved the following rates for inpatient 
and outpatient medical care provided by IHS facilities for Calendar 
Year 2022 for Medicare and Medicaid beneficiaries, beneficiaries of 
other federal programs, and for recoveries under the Federal Medical 
Care Recovery Act (42 U.S.C. 2651-2653). The inpatient rates for 
Medicare Part A are excluded from the table below. That is because 
Medicare inpatient payments for IHS hospital facilities are made based 
on the prospective payment system, or (when IHS facilities are 
designated as Medicare Critical Access Hospitals) on a reasonable cost 
basis. Since the inpatient per diem rates set forth below do not 
include all physician services and practitioner services, additional 
payment shall be available to the extent that those services are 
provided.

Inpatient Hospital per Diem Rate (Excludes Physician/Practitioner 
Services)
Calendar Year 2022
    Lower 48 States: $4,239
    Alaska: $3,583
Outpatient per Visit Rate (Excluding Medicare)
Calendar Year 2022
    Lower 48 States: $640

[[Page 20879]]

    Alaska: $945
Outpatient per Visit Rate (Medicare)
Calendar Year 2022
    Lower 48 States: $541
    Alaska: $792
Medicare Part B Inpatient Ancillary per Diem Rate
Calendar Year 2022
    Lower 48 States: $813
    Alaska: $1,138

Outpatient Surgery Rate (Medicare)

    Established Medicare rates for freestanding Ambulatory Surgery 
Centers.

Effective Date for Calendar Year 2022 Rates

    Consistent with previous annual rate revisions, the Calendar Year 
2022 rates will be effective for services provided on or after January 
1, 2022, to the extent consistent with payment authorities, including 
the applicable Medicaid State plan.

Elizabeth A. Fowler,
Acting Director.
[FR Doc. 2022-07468 Filed 4-7-22; 8:45 am]
BILLING CODE 4165-16-P
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-START>                             JAN-01-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                         1032559
<SECURITIES>                                         0
<RECEIVABLES>                                    22438
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               1065825
<PP&E>                                        16279241
<DEPRECIATION>                                 3547353
<TOTAL-ASSETS>                                13797713
<CURRENT-LIABILITIES>                           535794
<BONDS>                                              0
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                    13261919
<TOTAL-LIABILITY-AND-EQUITY>                  13797713
<SALES>                                        1705797
<TOTAL-REVENUES>                               1838579
<CGS>                                                0
<TOTAL-COSTS>                                  1382435
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 456144
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-PRIMARY>                                    10.88
<EPS-DILUTED>                                        0
        

</TABLE>